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Background: A case is reported of acute bilateral myopia and angle closure glaucoma in a 7-year-old patient from
topiramate toxicity. This is the second known reported case of topiramate induced acute angle closure glaucoma
and third known reported case of topiramate induced acute myopia in a pediatric patient.
Case presentation: This case presents a 7-year-old who had recently begun topiramate therapy for seizures and
headache. She developed painless blurred vision and acute bilateral myopia, which progressed to acute bilateral
angle closure glaucoma. After a routine eye exam where myopia was diagnosed, the patient presented to the
emergency room with symptoms of acute onset blurry vision, tearing, red eyes, swollen eyelids, and photophobia.
The symptoms, myopia, and angle closure resolved with topical and oral intraocular pressure lowering medications,
topical cyclopentolate, and discontinuation of topiramate.
Conclusion: Acute angle closure glaucoma is a well-known side effect of topiramate, but is rarely seen in children. It
cautions providers to the potential ophthalmic side effects of commonly used medications in the pediatric population.
It highlights the need to keep a broad differential in mind when encountering sudden onset blurry vision in the
primary care clinic, the need for careful consideration of side effects when starting topiramate therapy in a child,
and the need for parental counseling of side effects.
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Acute angle closure glaucoma (ACG) from topiramate
toxicity is well reported in adults. The largest case
series was published in 2004 by Fraunfelder et al. [1] of
83 bilateral and 3 unilateral cases. Of these, almost 50%
had been using 50 mg or less of topiramate. Eighty-five
percent of these cases occurred within the first 2 weeks,
with an overall mean of 7 days. There were 5 cases that
occurred within hours when the dose of topiramate was
doubled. These reported findings of most likely occurrence
within 2 weeks and a dosage under 50 mg have been
replicated in another large case series [2].
Topiramate is a sulfamate-substituted monosaccharide
and works via blockage of voltage-gated sodium channels,
hyperpolarization of potassium currents, enhancement of
postsynaptic GABA receptor activity, and suppression of* Correspondence: Yuna.rapoport@vanderbilt.edu
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unless otherwise stated.AMPA/kainite receptor. It is absorbed rapidly after oral
intake and crosses the blood–brain barrier. It is mostly
excreted in the urine, and has an elimination half-life of
21 hours [2]. In children, it was initially approved in July
1999 as adjunctive treatment for patients 2 years of age and
older with partial onset seizures. Later, it was approved
for seizures associated with Lennox-Gastaut syndrome,
generalized tonic clonic seizures, and as initial monother-
apy for partial onset or primary generalized epilepsy.
Topiramate has been approved in the adult population
as preventive therapy for headache and migraine and is
used off-label for these conditions in the pediatric popu-
lation. In 2011, the pediatric population (0–16 years)
accounted for 7% of total use of topiramate with 2.1 million
prescriptions and 315,000 patients; 81% of pediatric
patients were aged 10–18 years [3].
Acute myopia and angle closure glaucoma are two of
many adverse side effects of topiramate. The underlying
mechanism of acute myopia and acute angle closureal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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body edema which causes relaxation of zonular fibers, lens
thickening, and anterior displacement of the lens -iris
complex. The iris bowing forward physically blocks the
drain of the eye, preventing aqueous fluid drainage.
This ultimately causes secondary ACG and myopia.
The ciliochoroidal effusion caused by sulphonamides is
an idiosyncratic response in the uveal tissue, and is dose
independent [4]. The hapten hypothesis postulates that re-
active drug metabolites bind to proteins, forming altered
proteins, which are recognized as foreign substances and
incite immune reactions [4]. A patient must receive a
sensitizing dose prior to inciting the immune reaction
with the subsequent dose. The risk of any adverse reaction
to a sulfonamide is 3% [5].
Most common ocular signs of acute ACG from topira-
mate include abnormal vision, acute intraocular pressure
elevation, acute myopia [6], microcystic corneal edema,
shallow anterior chamber [1], circumciliary congestion,
retinal striae [7], macular folds, choroidal detachments,
and ciliochroidal detachments [8]. Besides topiramate,
other sulfonamides have been reported to cause a similar
clinical syndrome, including acetazolamide [9], sulfasalazine
[10], hydrochlorothiazide [10], and indapamide [4,11]. All
ocular findings are reversible if recognized early and the
drug is discontinued.
Treatment includes immediate discontinuation of topir-
amate, aqueous suppressants including oral or intravenous
(IV) acetazolamide and IV mannitol, topical beta blockers,
topical carbonic anhydrase inhibitors, topical prostaglandin
analogues, and topical cycloplegics such as cyclopentolate
or atropine, which work by relaxing the ciliary processes
and deepening the anterior chamber. Acute angle closure
usually resolves within 24–48 hours with medical treat-
ment, and myopia resolves within 1–2 weeks of discon-
tinuing the topiramate. If refractory, other measures
reported to be successful include oral/ IV steroids [12],
argon laser peripheral iridoplasty [13], and surgical inter-
vention including choroidal drainage [14], vitrectomy,
cataract extraction/ intraocular lens placement, and other
glaucoma surgeries.
While there are numerous case reports in the literature
of adults presenting with acute ACG from topiramate
toxicity in addition to the two case series mentioned
above, there are very few case reports in children. One
article reports acute myopia in an 8-year-old male with
a 6 diopter myopic shift without ACG [15], and one re-
ports a 5-year-old female presenting with acute ACG
and acute myopia [16].
This is the second known reported case of acute ACG
in a pediatric patient. In this case report, we discuss the
presentation, treatment, and resolution of symptoms, and
discuss a differential diagnosis of pediatric narrow angles
and of elevated intraocular pressure in a child with seizures.We discuss the potential differences between presentation
and treatment in the adult and pediatric population. We
stress the importance of careful consideration of side effects
when starting topiramate therapy in a child, and the need
for parental counseling of side effects.
Case presentation
History of present illness and review of systems
A 7-year-old female with a history of seizures and head-
aches presented to the pediatric emergency room (ER)
with acute onset of blurry vision. The morning of pres-
entation, she awoke with blurry vision. She presented to
her pediatrician, who referred her to an optometrist,
where she was refracted to a visual acuity (VA) of 20/20
with a myopic refraction. Visual acuity had been 20/20
at distance previously. Acute myopia is not an altogether
unusual presentation to an optometrist and generally a
new myopia patient does not cause alarm. She continued
to experience worsening vision accompanied with red
eyes, swollen eyelids, excessive tearing and photophobia.
She denied pain, burning, itching, mucus discharge, or
pain with extraocular movements. She denied systemic
symptoms including dizziness, nausea, vomiting, malaise,
neck stiffness, fever, or any focal neurological complaints.
Her last dose of topiramate was 25 mg, 20 hours prior to
presentation.
Past medical, surgical, ocular, medication, social and
allergic history
She had had 3 focal seizures from age 3–4, and had been
treated with levetiracetam until 3 months prior to pres-
entation, having been seizure free for three years. Her
headaches returned, and she had one seizure while in
school, which consisted of dysconjugate eye movements
and brief unresponsiveness. After consultation with her
primary pediatrician and her neurologist, topiramate 25 mg
at bedtime was started 2 weeks prior to presentation. Her
only other medication was cyproheptadine 5 ml at bedtime,
as needed. She had no other medical or surgical history.
Social, allergic and family history was noncontributory.
She was developing normally.
Examination
In the emergency room, her VA without correction was
light perception at 20 feet in both eyes, count fingers at
14 inches in both eyes, and 20/20 at 3 inches in both
eyes. In a complete ophthalmologic examination, vision
is typically tested at distance (20 feet) and at near (14
inches). In this patient’s case, vision was also checked at
2 inches because anteriorization of the lens leading to
acute myopia was suspected. Pupils were 6 mm, minimally
reactive, with no relative afferent papillary defect in either
eye. Extraocular movements were intact. Fields were
constricted 360 degrees to confrontation in both eyes.
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right eye and 41 mmHg in the left eye, as measured by
tonometry using a portable tonopen. External exam
was significant for slightly edematous upper and lower
lids. On slit lamp exam, sclera and conjunctiva showed
1+ injection, with conjunctival chemosis temporally bi-
laterally. There was no corneal edema. The anterior
chamber was diffusely shallow bilaterally. The irides were
round with a regular insertion, without iris bombe. There
was irido-corneal touch as seen by the Van Herick method
[17]. The lenses were clear. Fundus exam showed a pink
and healthy optic disc in both eyes with sharp margins,
with a cup: disc ratio of 0.25. The rest of the fundus exam-
ination was unremarkable. No choroidal effusions were
seen.
Treatment
Upon diagnosis with topiramate-induced acute ACG,
she was treated with oral acetazolamide 10 mg/kg × 2
doses, and 5 rounds of topical dorzolamide/timolol and
topical bimatoprost in both eyes. Her IOP decreased to
28 mmHg in the right eye, 29 mmHg in the left eye, and
her symptoms improved. She was no longer photopho-
bic, the eyelid edema had subsided, and VA was now
20/60 at 14 inches. She was discharged home overnight
with topical dorzolamide/timolol twice daily in both
eyes, oral acetazolamide 10 mg/kg three times daily ×
3 days, and topical cyclopentolate three times daily in
the right eye. Topiramate was discontinued and was
placed on her allergy list.Figure 1 Clinical and imaging findings. A. Slit lamp exam of the right ey
slightly injected conjunctiva. B. Normal slit lamp photograph of the right e
the right eye demonstrating abnormal anterior iris convexity, iridocorneal a
segment OCT of the right eye demonstrating horizontal iris, no iridocorneaClinical course
She was followed in the clinic closely. The day after her
initial presentation, her VA was 20/200 in the right eye,
20/150 in the left eye at distance (20 feet), and 20/60 in
the right eye, 20/40 + 3 in the left eye at near (14 inches);
IOP was 23 mmHg in the right eye, 21 mmHg in the left
eye, and all medications were continued. Her slit lamp
examination was unchanged (Figure 1a). In the pediatric
population in whom gonioscopy examination is very dif-
ficult, anterior segment optical coherence tomography
(OCT) is a useful way of discerning anatomy of the
angle and the anterior chamber. Anterior segment OCT
(Visante; Jena, Germany) in our patient showed anterior
iris convexity, iridocorneal apposition at the angle, and
an anterior lens vault in both eyes (Figure 1c). All medi-
cations were discontinued at eight days after presenta-
tion, when her VA was 20/25 + 3, 20/25 at distance, and
IOPs were 12 mmHg in the right eye, 11 mmHg in the
left eye. At her last follow up visit 2 months after initial
presentation, VA and IOP were normal off medications.
She had remained headache and seizure free. Repeat slit
lamp photograph (Figure 1b) and anterior segment OCT
(Figure 1d) demonstrated return to normal anatomy.
The anterior chambers were deep, and there was no
iridocorneal touch, anterior iris convexity, or anterior
lens vault in both eyes.
Conclusion
This case highlights the fact that drug-induced angle
closure, while rare in the pediatric population, should bee demonstrating diffusely shallow AC, large pupils, no K edema, and
ye after resolution of acute angle closure C. Anterior segment OCT of
pposition at the angle, and an anterior lens vault D. Normal anterior
l apposition, anterior iris convexity, or anterior lens vault.
Table 1 Differential diagnosis of childhood narrow angles
Anterior segment dysgenesis Posterior ‘Pushing’ mechanism
Corneal anomalies: microcornea, cornea plana/sclerocornea Anterior rotation of ciliary body
Axenfeld-Rieger syndrome, Peters anomaly, Aniridia Nanophthalmos, Inflammation (scleritis, uveitis, juvenile idiopathic arthritis)
Ectopia lentis (trauma, homocystinuria, Marfan syndrome,
Ehlers’-Danlos, syndrome, Weill-Marchesani syndrome
Drug-induced
Pupillary block Pressure from posterior segment
Aphakia Tumor (retinoblastoma, medulloepithelioma)
Microspherophakia Exudative retinal detachment
Anterior “Pulling’ mechanism without pupillary block Contraction of retrolental tissue
Neovascular (tuberous sclerosis) Persistent fetal vasculature
Peripheral anterior synechiae Retinopathy of prematurity
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blurry vision and have features of bilateral acute angle
closure, myopic shift and elevated intraocular pressure.
Other considerations in a child with narrow angles
similarly caused by a ciliochoroidal effusion include
scleritis, uveitis, juvenile idiopathic arthritis, tumors such
as retinoblastoma and medulloepithelioma, and exudative
retinal detachments. A full differential is presented here,
organized by mechanism (Table 1). The patient’s history
of seizures and presentation with elevated IOP is in
hindsight clearly linked to topiramate, but upon initial
consideration those two features could be linked in and
of themselves. Childhood phacomatoses such as Sturge
Weber, Klippel-Trenaunay-Weber Syndrome, Wyburn-
Mason syndrome, tuberous sclerosis, and neurofibroma-
tosis I, as well as Aicardi Syndrome, the Ring 14 Syndrome
[18], and CASK mutation [19] all present with epilepsy in
childhood and have different mechanisms of elevating
IOP (Table 2).
A thorough history and examination should eliminate
most of the previous entities from consideration. As thisTable 2 Differential diagnosis of elevated intraocular pressur
Aicardi syndrome Microphthalmos
CASK mutation Anterior segement dysgenesis,
megalocornea
Klippel-Trenaunay-Weber syndrome Increased episcleral venous pressure
Neurofibromatosis Anterior segment dysgenesis
Ring 14 syndrome Unknown
Sturge Weber syndrome Increased episcleral venous pressure
Tuberous sclerosis Anterior segment neovascularization
retinal detachment
Wyburn-Mason syndrome Intraocular hemorrhage
Diagnosis Intraocular Pressure Elevation Mechanism Other Clinical Findings.is the second known reported independent case report
of childhood ACG from topiramate, it is difficult to draw
conclusions as to differences between the clinical pres-
entation and course between children and adults. Since
they are both caused by the same mechanism, the same
course and outcome is assumed to occur. Treatment is
the same as in adults except topical alpha agonists are
contraindicated in children. Further investigation and
reports will help elucidate potential differences between
adults and children.
In comparison with the one other case of pediatric
ACG from topiramate [16], our patient did not present
with headache, nausea, and fatigue, had a slightly
lower IOP (40 vs. 50 mmHg), did not show microcys-
tic corneal edema, but did have iridocornreal touch. In
addition to pressure-lowering medications, a thorough
review of systemic medications should be undertaken
with discontinuation of the most probable causative
agent. A high index of suspicion for drug-induced
causes will allow for a quick diagnosis and complete
visual recovery.e and seizures in children
Agenesis of corpus callosum, depigmented chorioretinal
lacunae
Dystonia, psychomotor retardation, severe, intellectual disability,
scoliosis, mild, dysmorphism, progressive microcephaly
Port-wine stains, venous and lymphatic malformations, soft tissue
hypertrophy of affected limbs
Optic nerve glioma, Lisch nodules, café au lait spots, neurofibromas,
freckling of intertriginous areas
Macular white spots, strabismus, short, stature, microcephaly, scoliosis
Port-wine stains, ipsilateral leptomeningeal, vascular
malformations
, Retinal astrocytic hamartomas, ash-leaf spots, adenoma sebaceum,
cardiac rhabdomyoma
Retinal racemose hemangiomas, arteriovascular, malformation with
dilated and tortuous shunt vessels
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angle closure glaucoma were highlighted by this case re-
port. The first presenting sign of acute angle closure from
topiramate toxicity may be blurring of vision bilaterally at
distance with normal vision at near, representing the
myopic shift, and occurs prior to symptoms and elevated
IOP. Eighty five percent of cases of IOP elevation occur
within two weeks of use. Finally, primary narrow angle
glaucoma is rare under 40 years of age, and secondary
angle closure glaucoma, particularly drug-induced ACG,
must be considered in pediatric patients.
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